Skip to Content

5661 DAN (Sulindac 150 mg)

Pill with imprint 5661 DAN is Yellow, Round and has been identified as Sulindac 150 mg. It is supplied by Watson Laboratories, Inc..

Sulindac is used in the treatment of familial adenomatous polyposis; gout, acute; ankylosing spondylitis; bursitis; juvenile rheumatoid arthritis (and more), and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Sulindac 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 5661 DAN

Sulindac 150 mg 5661 DAN
Sulindac 150 mg 5661 DAN Front
Sulindac 150 mg 5661 DAN Back
Sulindac 150 mg 5661 DAN


5661 DAN
150 mg
10.00 mm
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
stearic acid
corn starch
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
66267-0264 Nucare Pharmaceuticals Inc. (repackager)
54868-0879 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.